This menu provides the list of EV miRNAs identified by high-throughput analyses.
Refresh all contents
Search:
Dataset accession
miRBase accession
Mature name
Orthologous group
Superdomain:
All
Prokaryote
Eukaryote
Filter datasets:
- "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
- "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
By species
Homo sapiens
In vitro/In vivo
In vitro
In vivo
By sample type
Drug-resistant acute lymphoblastic leukemia cell (CCRF-CEM MDR variant VLB100)
Drug-resistant breast adenocarcinoma cell (MCF-7 MDR variant MCF-7/DX)
Embryonic kidney cell (HEK293T)
Liver cancer cells (CSQT-2)
Malignant melanoma cell (A375)
Plasma
Seminal plasma
Serum
By sample status
Colorectal cancer_stage2_after_resection
Normal
Normal_Exiqon
Transplant islets into mouse xenotransplantation-rejected
Type 1 diabetes
Vasectomy
Vasovasostomy
miR-146a-treated
Maximum false positive rate (FPR):
Maximum true positive rate (TPR):
- FPR is the probability that an absent miRNA accidently have higher intensity than that miRNA.
- TPR is the percentile of miRNA among the present miRNAs.
Please see user manual in the contact us/help menu for detail.
Number of molecules in one page:
100
200
All
The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.
Since there are multiple primers in the microarray, the same miRNA can have several FPR and TPR values.
Mature name
miRBase accession
FPR
TPR
Publication
Orthologous group
Identification count
All / Prokaryote / Eukaryote
(FPR<0.05,TPR<0.5)
hsa-miR-1307-3p
MIMAT0005951
5.6e-16
4.7e-1
Microparticle conferred microRNA profiles--implications in the transfer and dominance of cancer traits.
Mol Cancer. 2012 Jun 8;11:37. doi: 10.1186/1476-4598-11-37.
MIPF0000558_2
13
/
0
/
13
hsa-miR-1307-3p
MIMAT0005951
1.5e-9
4.8e-1
Microparticle conferred microRNA profiles--implications in the transfer and dominance of cancer traits.
Mol Cancer. 2012 Jun 8;11:37. doi: 10.1186/1476-4598-11-37.
MIPF0000558_2
13
/
0
/
13
hsa-miR-1307-3p
MIMAT0005951
2.1e-12
4.0e-1
Selective extracellular vesicle-mediated export of an overlapping set of microRNAs from multiple cell types.
BMC Genomics. 2012 Aug 1;13:357. doi: 10.1186/1471-2164-13-357.
MIPF0000558_2
13
/
0
/
13
hsa-miR-1307-3p
MIMAT0005951
5.7e-9
4.8e-1
Selective extracellular vesicle-mediated export of an overlapping set of microRNAs from multiple cell types.
BMC Genomics. 2012 Aug 1;13:357. doi: 10.1186/1471-2164-13-357.
MIPF0000558_2
13
/
0
/
13
hsa-miR-1307-3p
MIMAT0005951
1.1e-16
4.1e-1
Identifying mRNA, microRNA and protein profiles of melanoma exosomes.
PLoS One. 2012;7(10):e46874. doi: 10.1371/journal.pone.0046874. Epub 2012 Oct 9.
MIPF0000558_2
13
/
0
/
13
hsa-miR-1307-3p
MIMAT0005951
0.0e+0
4.5e-1
microRNA signature is altered in both human epididymis and seminal microvesicles following vasectomy.
Hum Reprod. 2013 Jun;28(6):1455-67. doi: 10.1093/humrep/det088. Epub 2013 Mar 28.
MIPF0000558_2
13
/
0
/
13
hsa-miR-1307-3p
MIMAT0005951
0.0e+0
4.2e-1
microRNA signature is altered in both human epididymis and seminal microvesicles following vasectomy.
Hum Reprod. 2013 Jun;28(6):1455-67. doi: 10.1093/humrep/det088. Epub 2013 Mar 28.
MIPF0000558_2
13
/
0
/
13
hsa-miR-1307-3p
MIMAT0005951
0.0e+0
4.2e-1
microRNA signature is altered in both human epididymis and seminal microvesicles following vasectomy.
Hum Reprod. 2013 Jun;28(6):1455-67. doi: 10.1093/humrep/det088. Epub 2013 Mar 28.
MIPF0000558_2
13
/
0
/
13
hsa-miR-1307-3p
MIMAT0005951
0.0e+0
4.9e-1
Circulating exosomal microRNAs as biomarkers of colon cancer.
PLoS One. 2014 Apr 4;9(4):e92921. doi: 10.1371/journal.pone.0092921. eCollection 2014.
MIPF0000558_2
13
/
0
/
13
hsa-miR-1307-3p
MIMAT0005951
2.7e-4
4.9e-1
Combined Evaluation of a Panel of Protein and miRNA Serum Exosome Biomarkers for Pancreatic Cancer Diagnosis Increases Sensitivity and Specificity.
Int J Cancer. 2014 Nov 12. doi: 10.1002/ijc.29324.
MIPF0000558_2
13
/
0
/
13
hsa-miR-1307-3p
MIMAT0005951
0.0e+0
0.0e+0
Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.
MIPF0000558_2
13
/
0
/
13
hsa-miR-1307-3p
MIMAT0005951
4.2e-3
4.7e-1
Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.
MIPF0000558_2
13
/
0
/
13
hsa-miR-1307-3p
MIMAT0005951
0.0e+0
4.1e-1
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000558_2
13
/
0
/
13
[1]